Skip to main content
Jiaying Zhang on Muck Rack

Jiaying Zhang

As seen in: Nature, Wiley Online Library, PLOS, Frontiers in Immunology, Frontiers in Public Health, MDPI, ACS Publications, BMC Cancer, Royal Society of Chemistry, BioRxiv and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jiaying

Contact Jiaying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ubiquitination of Smad2 by Smurf1 inhibits endothelial-to-mesenchymal transition in human coronary artery endothelial cells

|
By Mingyang Zhang, Shuhui Wang, Zhiheng Liu, Nana Wang, Zhiyuan Liu, Yiyi Shen, Jiaying Zhang, Jing Li, Ying Liu, Haitao Lv, Guanghui Qian
| Nature Verified
Abstract Smad2 is a well-established regulator involved in tissue development and in the pathogenesis of endothelial-to-mesenchymal transition (EndMT) mediated by TGF-β signaling. However, the mechanism underlying the regulation of SMAD2 in human coronary artery endothelial cells (HCAECs), particularly the identity of the responsible E3 ubiquitin ligase and its role during EndMT remain unclear.
Open in Who Shared Issue with article?

Exploring sequential snapping bifurcation through a tunable energy landscape

|
By Ke Huang, Jiaying Zhang, Weicheng Huang
| American Physical Society
Opens in a new window Opens an external website Opens an external website in a new window This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. You may change your settings at any time or accept the default settings. You may close this banner to continue with only essential cookies. Privacy Policy Targeted advertising Personalization Analytics Username Password Enter a citation
Open in Who Shared View Duplicates (77) Issue with article?

Development, validation, and cost-effectiveness analysis of an AI-assisted three-tiered glaucoma screening model in a community-based setting: protocol for a cluster randomized controlled trial

|
By Xiangyu Fu, Jiaying Zhang, Xi Liu, Haotian Xiang, Xianjie Yu, Meng Wang, Yutong Liu, Li Tang, Shanming Jiang
| Frontiers in Public Health Verified
Abstract Introduction: Glaucoma is the leading irreversible blinding eye disease worldwide and the global prevalence of glaucoma for individuals aged 40–80 years is estimated as 3.54%. Early screening and prevention wherever possible are essential interventions of chronic disease management for glaucoma, but there is currently a lack of a recognized glaucoma screening model for Chinese population.
Open in Who Shared Issue with article?
See all 61 licensed articles (66 Total)